Unlock Tremendous Growth Opportunities in the Cell & Gene Therapy Market Across Europe, Germany, and the US with Exclusive Focus Reports by Arizton
Arizton provides information related to the industry's key issues, existing market landscape, regulatory concerns, risks & opportunities, technology evolution, and future commercial potential.
This report provides a comprehensive and current market scenario of the cell & gene therapy market, including market size, anticipated market forecast, relevant market segmentations, and industry trends.
Advancements in Europe Cell & Gene Therapy - A Closer Look at Recent Developments
The Europe cell and gene therapy market to witness robust growth with a CAGR of 38.20% between 2022- 2028.
To Get a Glimpse of our Report, Download the Free Sample Report: https://www.focusreports.store/request-sample/europe-cell-gene-therapy-market-focused-insights
The market is experiencing steady growth, primarily driven by the region's advanced healthcare infrastructure, widespread acceptance of cell & gene therapies, and substantial per capita healthcare spending in several developed European nations. Projections indicate that by 2028, the market is poised to expand nearly sevenfold compared to its present value. This remarkable growth can be attributed to the continuous approval of new products and an annual rise in the number of patients targeted for treatment. The ongoing conduct of clinical trials for cell and gene therapies and the introduction of expanded treatment options are expected to exert a significant and enduring influence on the market's trajectory.
In December 2022, Anocca secured €25 million ($26.5 million) in venture debt financing from the European Investment Bank (EIB). This financing aims to advance the first generation of T-cell immunotherapies toward clinical trials in a solid tumor indication during 2024.
In December 2022, uniQure and its partner CSL received a positive opinion recommending conditional marketing authorization (CMA) from CHMP for etranacogene dezaparvovec for treating adults with hemophilia B.
Myrtelle announced that the European Medicines Agency (EMA) granted orphan drug (OD) designation for rAAV-Olig001-ASPA for treating Canavan disease.
Germany Cell and Gene Therapy Market InsightsThe Germany cell and gene therapy market will grow at a compound annual growth rate (CAGR) of 40.15% from 2022-2028.
The cell & gene therapy market in Germany is growing gradually due to advanced healthcare infrastructure, high acceptance of cell & gene therapies, and high per capita healthcare expenditure. Novartis, Spark Therapeutics, Amgen, Gilead Sciences, Orchard Therapeutics, and Organogenesis are the leading players in the Germany cell & gene therapy market with significant shares. Vendors such as BioMarin Pharmaceuticals, PTC Therapeutics, Bristol-Myers Squibb, and Legend Biotech/Janssen Pharma are some of the other prominent players with a significant presence in the market.
To Get a Glimpse of our Report, Download the Free Sample Report: https://www.focusreports.store/request-sample/germany-cell-gene-therapy-market
Vendors are conducting clinical trials to gain regulatory approval in countries and regions with substantial untapped potential. Vendors are majorly targeting the Europe markets and are actively conducting clinical studies to gain regulatory approval and extend their presence in these significant markets for cell & gene therapy products. The European market provides the required cell & gene therapy product development facilities, so major vendors are entering the European market.
Rapid Growth & Evolution of Gene Therapy Dominating the US Cell & Gene Therapy Market
The US cell and gene therapy market will grow at a compound annual growth rate (CAGR) of 41.25% during 2022-2028.
To Get a Glimpse of our Report, Download the Free Sample Report: https://www.focusreports.store/request-sample/us-cell-gene-therapy-market-focused-insights
The US is the fastest-growing market for cell & gene therapy products globally. The cell & gene therapy market in the US is growing at a healthy rate due to the presence of advanced healthcare infrastructure, high acceptance of cell & gene therapies, and high per capita healthcare expenditure in different states of the US. Based on therapy, the gene therapy segment dominated the US cell & gene therapy market in 2022 with a share of 76.95%. However, this scenario is likely to change as the number of product introductions in gene therapy and better management of the process using advanced vectors will increase the adoption of gene therapy during the forecast period. As a result, the segment will grow to 94.69% in 2028.
In November 2022, CSL announced that the US FDA approved HEMGENIX (etranacogene dezaparvovec-drlb) for appropriate adults with hemophilia B.
In November 2022, Tenaya Therapeutics received an Orphan Drug Designation from the US Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy.
In November 2022, Sensorion announced that the US FDA granted rare pediatric disease designation to its lead therapy gene candidate, OTOF-GT.
In September 2022, bluebird bio announced the US FDA granted Accelerated Approval of SKYSONA (elivaldogene autotemcel) to slow the progression of neurologic dysfunction in boys of 4-17 years of age with early active cerebral adrenoleukodystrophy (CALD).
The Report Provides Focused Insights Across the Following Sections.
US cell and gene therapy Historic & projected revenues across 2022 - 2028 across all segments
Market opportunities & trends
Marketed Cell & Gene Therapies Overview, Recent Approvals in the US
Pipeline drug landscape across major players & drug profiles.
Total clinical trials, including cell therapies & gene therapies.
Competitive Scenario of Gene Therapy & Cell Therapy Vendors
Pricing and Reimbursement Scenario
Buy this Reports @
Europe Cell & Gene Therapy Market - Focused Insights 2023-2028
Germany Cell & Gene Therapy Market- Focused Insights 2023-2028
US Cell & Gene Therapy Market - Focused Insights 2023-2028
About Focused Reports by Arizton
Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.
+1 302 469 0707
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Unlock Tremendous Growth Opportunities in the Cell & Gene Therapy Market Across Europe, Germany, and the US with Exclusive Focus Reports by Arizton here
News-ID: 3229308 • Views: 197
More Releases from Arizton Advisory & Intelligence
Global Body Contouring Devices Market Size to Reach USD 12.6 Billion by 2027 - A …
According to Arizton's latest research report, the body contouring devices market will grow at a CAGR of 14% from 2022-2027. The global market for body contouring devices is expanding due to the rising demand for medical aesthetics treatments. Medical aesthetics is rapidly growing due to the large aging population and advanced procedure launches. At present, micro-needling and skin tightening treatments are some medical aesthetic treatments with the highest global demand.
The Dental Water Flosser Market to Hit $1.27 Billion by 2028 - Arizton
According to Arizton's latest research report, the dental water flosser market is growing at a CAGR of 6.20% during 2022-2028. To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/4008 The adoption rate of dental water floss among end-users globally has been impressive. Due to the increased demand, the market has witnessed the entry of several new vendors. The competition among these companies has intensified, leading to the introduction of many
Nutraceuticals Market to Reach $693.06 Billion by 2028, Industry Analysis Report …
According to Arizton's latest research report, the nutraceuticals market is growing at a CAGR of 8.47% during 2022-2028. To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/4014 The global nutraceuticals market by product is segmented into functional foods, functional beverages, and vitamins. In 2022, the functional foods segment accounted for a 45.01% market share and is expected to dominate the market during the forecast period. Functional food products are nutrient-rich
Iceland Data Center Market to Witness Investment of USD 543 Million by 2028 - Ar …
According to Arizton's latest research report, the Iceland data center market will grow at a CAGR of 12.63% from 2022 to 2028. Get Insights on 07 Existing Data Centers and 1 Upcoming Facility across Iceland. To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/4031 Data center investments in Iceland over the next 2-3 years expect to be aggressive and high due to investments from local operators. The market is
More Releases for Gene
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Gene editing or Genome editing is
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product